Blockchain provides transparent, tamper-proof, and decentralized ledgers, ensuring the fairness of games and the security of transactions. E-commerce platforms are adopting cryptocurrencies and ...
On Windows 11, desktop elements like the Taskbar, Start menu, and certain apps, such as the Settings app, use a new transparent base layer featuring the Mica material from the Microsoft Fluent ...
How did you do today? Send me an email and let me know. Strands is the NYT's new word game, following Wordle and Connections. It's now out of beta so is a fully fledged member of the NYT's games ...
In an era where information flows instantly, and workplace dynamics constantly shift, the question isn't whether to be transparent—it's how to make transparency a competitive advantage in the ...
The former Turkish soap star threw herself into a racy game in the villa before snogging Curtis Pritchard who she'd stolen off Kaz Crossley. Ekin-Su has already delivered some jaw-dropping moments ...
Ah, the scorpion lollipop, a symbol of the Sonoran Desert. I like them, if only for the campiness of the dark, goth-looking scorpion encased unhappily in a gentle green, pink or blue. That said, ...
Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...
Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan Healthcare Conference with a deal to buy Scorpion Therapeutics ...
We look forward to leveraging the great work of the Scorpion team to date, along with Lilly's deep expertise in breast cancer, to further advance STX-478 with speed and focus." Under the terms of ...
Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of ...
SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.